Cingulate therapeutics headquarters
WebJun 16, 2024 · Cingulate Therapeutics, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment … WebJun 24, 2024 · Virtual. We are pleased to invite you to a virtual call series highlighting the next generation of life sciences private companies from Monday, June 29 th – Thursday, July 2 nd, 2024. We will be hosting the companies for 35 minute presentations with time for Q&A over the four days.
Cingulate therapeutics headquarters
Did you know?
WebCingulate Therapeutics has raised a total of $7.6M in funding over 3 rounds. Their latest funding was raised on Jul 11, 2024 from a Venture - Series Unknown round. Cingulate Therapeutics is registered under the ticker NASDAQ:CING . Their stock opened with $6.00 in its Dec 8, 2024 IPO. WebCingulate General Information. Description. Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery …
WebDec 8, 2024 · Cingulate Therapeutics (CTx) is a privately held, clinical-stage biopharmaceutical company focused on the development of products for the treatment … WebCingulate currently has two (2) product candidates, CTX-1301 and CTX-1302, that are being developed to serve the approximate $18 billion annual U.S. ADHD market. A third product candidate, CTX-2103, is being developed to serve the roughly $5 billion U.S. … 10 Mar 2024 Cingulate Inc. Reports Fourth Quarter and Full Year 2024 Financial … Pipeline Overview. Cingulate® completed a proof-of-concept trial in human subjects … Cingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 … Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and … About Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage … Mr. Gallagher is a Co-Founder of Cingulate Therapeutics and serves as a member …
WebCingulate Therapeutics Primary Sponsor contact: Holly Mitzel Cingulate Therapeutics 1901 W. 47th Place, Suite 310 Kansas City, KS 66205 E: [email protected] P: 913-942-2304 Secondary Sponsor contact: Matt Brams, MD Cingulate Therapeutics 1901 W. 47th Place, Suite 310 Kansas City, KS … WebMar 10, 2024 · KANSAS CITY, Kan., March 10, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug...
WebOct 13, 2024 · Founded in 2013, Cingulate is a clinical-stage biopharmaceutical company. The company uses its proprietary Precision Timed Release (PTR) drug delivery platform technology to treat patients with...
WebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that it has moved the location of … how much money is 50k views on youtubeWebApr 3, 2024 · Cingulate Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry. Cingulate Therapeutics's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and … how much money is 60 000 robuxWebAmendment to Employment Agreement, effective April 1, 2024, between Cingulate Therapeutics LLC and Raul R. Silva Cingulate Inc. Reports First Quarter 2024 Results and Provides Clinical and Business Update Announcement of First Subject Dosing for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ … how much money is 550 pesosWebMr. Peter Werth serves as Board Member at Cingulate Therapeutics. He is the Founder and also serves as Chief Executive Officer at Werth Ventures. He serves as Board Member at Alopexx Enterprises. He is the Owner & serves as the Chief Executive Officer & President at Chemwerth. He also served as a board member at InnoPharma. how do i save a web pageWebDec 8, 2024 · KANSAS CITY, Kan., Dec. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing... how do i save a voice message on my iphoneWebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on... how do i save a word document without markupsWebJun 15, 2024 · Kansas City, KS – (June 15, 2024) – Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that it has moved the location of its Kansas City headquarters. how do i save a word document as a zip file